Semi-rigid analogues of the calcium antagonist verapamil: A molecular modelling study
暂无分享,去创建一个
Maria Novella Romanelli | Raimund Mannhold | Silvia Dei | Serena Scapecchi | Fulvio Gualtieri | Elisabetta Teodori | Roberta Budriesi | R. Mannhold | R. Budriesi | S. Dei | E. Teodori | M. Romanelli | S. Scapecchi | F. Gualtieri
[1] A. Chiarini,et al. Verapamil analogues with restricted molecular flexibility: synthesis and pharmacological evaluation of the four isomers of alpha-[1-[3-[N-[1- [2-(3,4-dimethoxyphenyl)ethyl]]-N-methylamino]cyclohexyl]]-alpha- isopropyl-3,4-dimethoxybenzene-acetonitrile. , 1993, Journal of medicinal chemistry.
[2] E. Uriarte,et al. Structure-activity relationships in verapamil and analogues using molecular mechanics calculations , 1992 .
[3] A. Chiarini,et al. Verapamil analogues with restricted molecular flexibility. , 1991, Journal of medicinal chemistry.
[4] C. Botré,et al. Nuclear magnetic resonance investigations of calcium antagonist drugs. II: Conformational and dynamic features of verapamil in [2H6]DMSO. , 1991, Journal of pharmaceutical sciences.
[5] A. Carpy,et al. Antagonistes calciques. I. Remplacement du groupe diméthoxy-3,4 phényléthyle du vérapamil , 1990 .
[6] P. Luger,et al. Specific bradycardic agents. 1. Chemistry, pharmacology, and structure-activity relationships of substituted benzazepinones, a-new class of compounds exerting antiischemic properties. , 1990, Journal of medicinal chemistry.
[7] W. Koch,et al. Toward an understanding of the dihydropyridine-sensitive calcium channel. , 1990, Biochemical pharmacology.
[8] R. Budriesi,et al. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates. , 1989, Farmaco.
[9] R. Mannhold,et al. A search for calcium-channel activators in the verapamil series. , 1989, Farmaco.
[10] G. Retzinger,et al. Evidence that uncharged verapamil inhibits myocardial contractility. , 1987, The Journal of pharmacology and experimental therapeutics.
[11] P. Chiang,et al. 6-Methyl-6-azabicyclo[3.2.1]octan-3 alpha-ol 2,2-diphenylpropionate (azaprophen), a highly potent antimuscarinic agent. , 1987, Journal of medicinal chemistry.
[12] G. Retzinger,et al. Ionization and surface properties of verapamil and several verapamil analogues. , 1986, Journal of pharmaceutical sciences.
[13] J. Robertson. High pressure in science and technology. Part 1. Collective phenomena and transport properties edited by C. Homan, R. K. MacCrone and E. whalley , 1985 .
[14] J. Leger,et al. Structure of α‐isopropyl‐α‐[(N‐methyl‐N‐homoveratryl)‐γ‐aminopropyl]‐3,4‐dimethoxyphenylacetonitrile hydrochloride, verapamil, C27H38N2O4.HCl , 1985 .
[15] J. P. Long,et al. Conformationally restricted congeners of dopamine derived from 2-aminoindan. , 1982, Journal of medicinal chemistry.
[16] J. Cannon,et al. Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration. , 1977, Journal of medicinal chemistry.
[17] Nayler Wg. Classification and tissue selectivity of calcium antagonists. , 1990 .
[18] H. Höltje,et al. Conformational analysis on calcium channel active diphenylalkylamines, diphenylbutylpiperidines, phenylalkylamines, and perhexiline , 1989 .
[19] C. Melchiorre,et al. RECENT ADVANCES IN RECEPTOR CHEMISTRY , 1988 .
[20] Chi-Ho Lee,et al. Synthesis and Determination of the Absolute Stereochemistry of the Enantiomers of 3-Substituted 1,2,3,4-Tetrahydroisoquinolines Related to the Calcium Antagonist Verapamil , 1987 .
[21] M. Frey,et al. Calcium antagonists: mechanisms and therapeutic uses , 1984 .